Gerd U. Auffarth, MD

New IOL, automated delivery system expected to transform market
Dr. David Apple's legacy endures through laboratoryWere he alive today, he would likely feel heartened by how his work has been carried on by Gerd U. Auffarth, MD, FEBO, who is now director of The David J Apple International Laboratory for Ocular Pathology at the University of Heidelberg, Germany.
Innovative IOL breaks new ground in presbyopia-correcting implant technology
Innovative IOL breaks new ground in presbyopia-correcting implant technologyA new presbyopia-correcting IOL has a novel optic combining two complementary diffractive technologies. Results from bench and clinical testing show it provides a full range of continuous, high-quality vision, minimizes dysphotopsias, and may be more tolerant to refractive errors than multifocal IOLs.